Non-Alcoholic Fatty Liver Disease (NAFLD) has become a major global health concern, affecting 38% of the population due to rising rates of obesity, diabetes, and sedentary lifestyles. Dr. Gyanranjan Rout, a Consultant-Medical Gastroenterologist, highlighted the importance of early diagnosis and proactive measures in managing NAFLD, which can progress to severe conditions if left untreated.
While no specific drugs are approved for treating NAFLD, lifestyle changes such as weight loss through a healthy diet and exercise are recommended. Dr. Rout emphasized the positive impact of Saroglitazar, vitamin E, and new treatments like obeticholic acid on liver function in NAFLD patients. It is crucial to control comorbid conditions like type 2 diabetes, hypertension, and hyperlipidemia to prevent complications of NAFLD.
Dr. Rout concluded that a combination of lifestyle interventions, medical treatment for associated conditions, and ongoing research for new therapies offer hope for improved outcomes in managing NAFLD. Early diagnosis and proactive measures are key in preventing and managing the disease. This article serves as informational purposes only and urges readers to consult a medical professional for individualized advice.
Note: The image is for illustrative purposes only and is not the original image associated with the presented article. Due to copyright reasons, we are unable to use the original images. However, you can still enjoy the accurate and up-to-date content and information provided.
